Contralateral second dose improves antibody responses to a 2-dose mRNA vaccination regimen.

Autor: Fazli S; Department of Occupational Health., Thomas A; Oregon National Primate Research Center, Division of Neuroscience, and., Estrada AE; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, USA., Ross HA; UCLA, Los Angeles, California, USA., Xthona Lee D; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, USA., Kazmierczak S; Department of Pathology, Oregon Health & Science University, Portland, Oregon, USA., Slifka MK; Oregon National Primate Research Center, Division of Neuroscience, and., Montefiori D; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Messer WB; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, USA.; Department of Medicine, Division of Infectious Diseases, Oregon Health & Science University, Portland, Oregon, USA.; Program in Epidemiology, Oregon Health & Science University, Portland State University School of Public Health, Portland, Oregon, USA., Curlin ME; Department of Occupational Health.; Department of Medicine, Division of Infectious Diseases, Oregon Health & Science University, Portland, Oregon, USA.; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, USA.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Jan 16; Vol. 134 (6). Date of Electronic Publication: 2024 Jan 16.

Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia.

Autor: Lyski ZL; Department of Molecular Microbiology & Immunology, Oregon Health & Science University (OHSU), Portland, OR 97239, USA., Kim MS; Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR 97239, USA., Xthona Lee D; Department of Molecular Microbiology & Immunology, Oregon Health & Science University (OHSU), Portland, OR 97239, USA., Sampson D; Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR 97239, USA., Raué HP; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97239, USA., Raghunathan V; Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR 97239, USA., Ryan D; Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR 97239, USA., Brunton AE; OHSU-PSU School of Public Health, Portland, OR 97239, USA., Slifka MK; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97239, USA., Messer WB; Department of Molecular Microbiology & Immunology, Oregon Health & Science University (OHSU), Portland, OR 97239, USA.; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97239, USA.; Department of Medicine, Division of Infectious Diseases, Oregon Health & Science University (OHSU), Portland, OR 97239, USA., Spurgeon SE; Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR 97239, USA.

Publikováno v: Case reports in hematology [Case Rep Hematol] 2022 Feb 04; Vol. 2022, pp. 6831640. Date of Electronic Publication: 2022 Feb 04 (Print Publication: 2022).